Egypt Dengue Treatment Market to 2032
Overview
The Egypt Dengue Treatment Market is expected to reach a 37.11 USD Million by 2032 and is projected to grow at a CAGR of 14.57% from 2025 to 2032.
Revenue, 2024 (USD Million)
14.11
Forecast, 2032 (USD Million)
37.11
CAGR, 2024 - 2032
14.57%
Report Coverage
Egypt
Egypt Dengue Treatment Market 2018-2032 USD Million
Egypt Dengue Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 14.11 USD Million
- Projected Market Size (2032): 37.11 USD Million
- CAGR (2025-2032): 14.57%
Key Findings of Egypt Dengue Treatment Market
- The Egypt Dengue Treatment Market was valued at 37.11 USD Million in 2024.
- The Egypt Dengue Treatment Market is likely to grow at a CAGR of 14.57% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Acetaminophen in Type Segment accounted for the largest share of the market with a revenue of 14.11 USD Million
- The fastest growing segment Home Healthcare in End User Segment grew Fastest with a CAGR of 15.50% during the forecast period from 2024 to 2032.
Egypt Dengue Treatment Market Scope
Egypt Dengue Treatment Market Segmentation & Scope
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Route of Administration
- Parenteral
- Oral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Type
- Acetaminophen
- Vaccines
Strains
- Others
- DENV-4
- DENV-1
- DENV-3
- DENV-2
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospital
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Egypt Dengue Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 14.11 USD Million |
| Market Value in 2032 | 37.11 USD Million |
| CAGR (2025-2032) | 14.57% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Route of Administration,Severity,Type,Strains,End User,Age,Gender,Mode of Purchase |
Regional Insights:
-
Leading Market (2024-2032): Egypt, leading in terms of revenue 14.11 USD Million in 2024
- Key Country: Egypt, leading in terms of revenue with value of 14.11 USD Million in 2024.
Segments and Scope
-
Egypt Dengue Treatment Market to 2032, By Distribution Channel
- Retail Pharmacies is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 7.92 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.68 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 11.88 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.68 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Severity
- Mild to Moderate Dengue is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 8.98 USD Million in the year 2024.
- Mild to Moderate Dengue is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.87 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Type
- Acetaminophen is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 14.11 USD Million in the year 2024.
- Acetaminophen is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.57 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Strains
- DENV-2 is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 5.61 USD Million in the year 2024.
- DENV-1 is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.39 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By End User
- Hospital is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 8.59 USD Million in the year 2024.
- Home Healthcare is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.80 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Age
- Adult is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 8.62 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.28 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Gender
- Male is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 10.38 USD Million in the year 2024.
- Male is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.78 % in forecast period 2025-2032.
-
Egypt Dengue Treatment Market to 2032, By Mode of Purchase
- Prescription is the largest segment in Egypt Dengue Treatment Market to 2032 with a revenue of 11.93 USD Million in the year 2024.
- Prescription is the Fastest growing segment in Egypt Dengue Treatment Market to 2032 with a Growth rate of 14.67 % in forecast period 2025-2032.
Egypt Dengue Treatment Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Takeda Pharmaceutical Company Limited | |||
| Sanofi | |||
| GSK plc. | |||
Egypt Dengue Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Egypt Dengue Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Egypt Dengue Treatment Market is segmented based on Segmentation Distribution Channel,Route of Administration,Severity,Type,Strains,End User,Age,Gender,Mode of Purchase.
Egypt Dengue Treatment Market was valued at USD 14.11(Revenue in USD Million) in 2022.
Egypt Dengue Treatment Market is projected to grow at a CAGR of 14.57% during the forecast period of 2024 to 2032.
The Acetaminophen segment is expected to dominate the Egypt Dengue Treatment Market, holding a largest market share of 14.11 USD Million in 2024
Egypt Dengue Treatment Market Scope
Egypt Dengue Treatment Market Segmentation & Scope
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Route of Administration
- Parenteral
- Oral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Type
- Acetaminophen
- Vaccines
Strains
- Others
- DENV-4
- DENV-1
- DENV-3
- DENV-2
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospital
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Frequently Asked Questions
The Egypt Dengue Treatment Market is segmented based on Segmentation Distribution Channel,Route of Administration,Severity,Type,Strains,End User,Age,Gender,Mode of Purchase.
Egypt Dengue Treatment Market was valued at USD 14.11(Revenue in USD Million) in 2022.
Egypt Dengue Treatment Market is projected to grow at a CAGR of 14.57% during the forecast period of 2024 to 2032.
The estimated market value of the Egypt Dengue Treatment Market for final year is USD 37.11 (USD Million).
Egypt Dengue Treatment Market Company Profiling
Frequently Asked Questions
The Egypt Dengue Treatment Market is segmented based on Segmentation Distribution Channel,Route of Administration,Severity,Type,Strains,End User,Age,Gender,Mode of Purchase.
Egypt Dengue Treatment Market was valued at USD 14.11(Revenue in USD Million) in 2022.
Egypt Dengue Treatment Market is projected to grow at a CAGR of 14.57% during the forecast period of 2024 to 2032.
The estimated market value of the Egypt Dengue Treatment Market for final year is USD 37.11 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.